1. Search Result

Search Result

Results for "808732-98-1" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-106441A
    Rislenemdaz

    MK-0657; CERC-301

    iGluR Neurological Disease
    Rislenemdaz (CERC-301) is an orally bioavailable and selective N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM, respectively.